Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$0.48 - $0.7 $3,360 - $4,900
-7,000 Reduced 9.33%
68,000 $38,000
Q4 2022

Feb 02, 2023

SELL
$0.96 - $1.34 $235,905 - $329,284
-245,735 Reduced 76.62%
75,000 $77,000
Q3 2022

Oct 12, 2022

SELL
$1.02 - $2.23 $2,040 - $4,460
-2,000 Reduced 0.62%
320,735 $423,000
Q2 2022

Jul 29, 2022

SELL
$0.94 - $1.94 $7,144 - $14,744
-7,600 Reduced 2.3%
322,735 $407,000
Q1 2022

May 10, 2022

BUY
$1.54 - $3.71 $13,444 - $32,388
8,730 Added 2.71%
330,335 $651,000
Q4 2021

Jan 18, 2022

BUY
$2.58 - $3.91 $265,623 - $402,554
102,955 Added 47.09%
321,605 $859,000
Q3 2021

Oct 26, 2021

BUY
$2.77 - $4.05 $605,660 - $885,532
218,650 New
218,650 $741,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $242M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Guild Investment Management, Inc. Portfolio

Follow Guild Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guild Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guild Investment Management, Inc. with notifications on news.